Diagnosis and Treatment of Patients Utilizing Complementary Medicine at a Tertiary Referral Hospital in Eastern Switzerland.

Schlegel T, Haegele-Link S, Bertotto C, Rieger U, Wittchow S, Schlaeppi M, Templeton AJ

Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors.

Kudura K, Ritz N, Kutzker T, Hoffmann MHK, Templeton AJ, Foerster R, Kreissl MC, Antwi K

Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence.

Christiansen AJ, Lobo J, Fankhauser CD, Rothermundt C, Cathomas R, Batavia AA, Grogg JB, Templeton AJ, Hirschi-Blickenstorfer A, Lorch A, Gillessen S, Moch H, Beyer J, Hermanns T

A social identity approach to COVID-19 transmission in hospital settings.

Hlubek N, Templeton A, Wiseman-Gregg K

Deep-branching acetogens in serpentinized subsurface fluids of Oman.

Colman DR, Kraus EA, Thieringer PH, Rempfert K, Templeton AS, Spear JR, Boyd ES

Structural variants identified using non-Mendelian inheritance patterns advance the mechanistic understanding of autism spectrum disorder.

Kainer D, Templeton AR, Prates ET, Jacboson D, Allan ERO, Climer S, Garvin MR

Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial.

ACTIV-3–Therapeutics for Inpatients with COVID-19 (TICO) Study Group

Social identity processes associated with perceived risk at pilot sporting events during COVID-19.

Smith K, Templeton A

Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial.

Montgomery H, Hobbs FDR, Padilla F, Arbetter D, Templeton A, Seegobin S, Kim K, Campos JAS, Arends RH, Brodek BH, Brooks D, Garbes P, Jimenez J, Koh GCKW, Padilla KW, Streicher K, Viani RM, Alagappan V, Pangalos MN, Esser MT, TACKLE study group

Transformation of low-molecular-weight organic acids by microbial endoliths in subsurface mafic and ultramafic igneous rock.

Fones EM, Templeton AS, Mogk DW, Boyd ES

Cancer Risk C (CR-C), a functional genomics test is a sensitive and rapid test for germline mismatch repair deficiency.

Alim I, Loke J, Yam S, Templeton AS, Newcomb P, Lindor NM, Pai RK, Jenkins MA, Buchanan DD, Gallinger S, Klugman S, Ostrer H

Correlation between hematological parameters and PET/CT metabolic parameters in patients with head and neck cancer.

Bojaxhiu B, Sinovcic D, Elicin O, Templeton AJ, Shelan M, Wartenberg J, Alberts I, Rominger A, Aebersold DM, Zaugg K

Plasma proteomics of SARS-CoV-2 infection and severity reveals impact on Alzheimer and coronary disease pathways.

Wang L, Western D, Timsina J, Repaci C, Song WM, Norton J, Kohlfeld P, Budde J, Climer S, Butt OH, Jacobson D, Garvin M, Templeton AR, Campagna S, O'Halloran J, Presti R, Goss CW, Mudd PA, Ances BM, Zhang B, Sung YJ, Cruchaga C

Modelling the tumor immune microenvironment for precision immunotherapy.

Mackenzie NJ, Nicholls C, Templeton AR, Perera MP, Jeffery PL, Zimmermann K, Kulasinghe A, Kenna TJ, Vela I, Williams ED, Thomas PB

Clinical benefit of cancer drugs approved in Switzerland 2010-2019.

Adam R, Tibau A, Molto Valiente C, Ĺ eruga B, OcaĂąa A, Amir E, Templeton AJ